Diverse binding poses of agonistic neurotoxins on human Na_v1.6

Arbuckle, K. Evolutionary context of venom in animals. Evol. Venom. Anim. Toxins 24, 3–31 (2017).

Huang, J., Pan, X. & Yan, N. Structural biology and molecular pharmacology of voltage-gated ion channels. Nat. Rev. Mol. Cell Biol. 25, 904–925 (2024).

de Lera Ruiz, M. & Kraus, R. L. Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. J. Med. Chem. 58, 7093–7118 (2015).

Armstrong, C. M. Na channel inactivation from open and closed states. Proc. Natl Acad. Sci. USA 103, 17991–17996 (2006).

Chanda, B. & Bezanilla, F. Tracking voltage-dependent conformational changes in skeletal muscle sodium channel during activation. J. Gen. Physiol. 120, 629–645 (2002).

Lazarovici, P. Snake-and spider-venom-derived toxins as lead compounds for drug development. Methods Mol. Biol. https://doi.org/10.1007/978-1-4939-9845-6_1 (2020).

Kalia, J. et al. From foe to friend: using animal toxins to investigate ion channel function. J. Mol. Biol. 427, 158–175 (2015).

Luz Morales-Lazaro, S., Hernández-García, E., Serrano-Flores, B. & Rosenbaum, T. Organic toxins as tools to understand ion channel mechanisms and structure. Curr. Top. Med. Chem. 15, 581–603 (2015).

Escoubas, P. & Bosmans, F. Spider peptide toxins as leads for drug development. Expert Opin. Drug Discov. 2, 823–835 (2007).

Gilchrist, J. & Bosmans, F. Using voltage-sensor toxins and their molecular targets to investigate Na V 1.8 gating. J. Physiol. 596, 1863–1872 (2018).

... continue reading